Versant Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Versant Capital Management's NEO Position: Q3 2026 in Review
Versant Capital Management held its NeoGenomics (NEO) position steady in Q3 2026 at 1,708 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1714.
Versant Capital Management first reported a position in NEO in Q1 2022 and has held it in 19 quarters since. 231 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- Versant Capital Management held 1,708 shares of NeoGenomics worth $31.4K as of Q3 2026.
- Versant Capital Management left its NeoGenomics share count unchanged in Q3 2026.
- NeoGenomics made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1714 holding.
- Versant Capital Management first reported a position in NeoGenomics in Q1 2022 and has held it in 19 quarters since.
- 231 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.